Rebecca Scarpa
Payments from drug & device makers
Across 80 payments — averaging $24.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$322
- GSK$319
- Novo Nordisk$143
- Biohaven Pharmaceuticals, Inc.$143
- Lilly USA, LLC$138
- Si-bone, Inc.$114
- plus $811 from 16 others
What the payments were for
- Food & beverage$1,991100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $322 |
| GSK | 11 | $319 |
| Novo Nordisk | 6 | $143 |
| Biohaven Pharmaceuticals, Inc. | 2 | $143 |
| Lilly USA, LLC | 7 | $138 |
| Si-bone, Inc. | 1 | $114 |
| AstraZeneca | 5 | $104 |
| Corcept Therapeutics | 4 | $102 |
| Dexcom, Inc. | 5 | $90 |
| Exact Sciences | 1 | $86 |
| Tactile Systems Technology Inc | 1 | $83 |
| Pfizer | 4 | $77 |
| Amgen | 3 | $57 |
| Boehringer Ingelheim | 3 | $51 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Merck | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$124
- AREXVY$122
How this compares
$1,991 in reported general payments places this provider in the 80th percentile of 1,501 family providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 16 | $160 |
| Levothyroxine Sodium | 15 | $85 |
| Trazodone Hcl | 16 | $67 |
Paid to pharmacies, not to this prescriber.
Other family in Reno
- Lisa Hammargren-KuykendallReno$22K
- Martha AiyukReno$15K
- Jocelyn AllenReno$12K
- Kaylie HumphreysReno$11K
- Christina KrainbrinkReno$10K
- Barbara SzatkowskiReno$10K
- Johanna LeeReno$9K
- Darin OldeReno$9K
- Ruth SkinnerReno$8K
- Anna EllisReno$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.